INTRODUCTION 1
Simian immunodeficiency viruses (SIVs) have been identified in over 40 African non-2 human primate (NHP) species (reviewed in 48, 73), although to date only sooty mangabeys 3 (SIVsmm), African green monkeys (SIVagm) and mandrills (SIVmnd), have been studied in 4 detail (reviewed in 47, 48, 70, 73) . Natural SIV infections share many similarities with 5 human immunodeficiency virus (HIV) infections, including high levels of viral replication 6 and marked depletion of mucosal CD4 + T cells during acute infection (reviewed in 47, 48, 70, 7 71). However, fundamental differences have also been identified. Most importantly, AGM 8
and SM hosts of SIV show only an early transient increase in immune activation and do not 9 develop AIDS (7, 10, 23, 30, 44, 49, 52, 67, 68) . 10
Comparisons of non-pathogenic and pathogenic primate lentiviral infections have become 11 an important area of AIDS research (reviewed in 29, 47, 50, 70) . It is now clear that host 12 factors can play an important role in the clinical outcome of infection. This is perhaps best 13 illustrated by the fact that SIV from SMs is usually non-pathogenic in its natural mangabey 14 host, but highly virulent in experimentally infected macaques (reviewed in 29, 47, 50, 70) . 15
Features that distinguish SMs and AGMs from macaques that may allow them to avoid 16 chronic immune activation and disease progression include effective regulatory T cell 17 responses that establish an anti-inflammatory milieu, reduced levels of CCR5 on the surface 18 of CD4 + T cells, and the maintenance of an intact mucosal barrier that prevents microbial 19 translocation (reviewed in 29, 47, 50, 70) . However, viral properties that differentiate 20 SIVagm and SIVsmm from HIV-1 and its chimpanzee precursor SIVcpz, such as the lack of 21 a vpu gene and the expression of Nef proteins that block the activation of virally infected T 22 cells by 64, 65) , may also contribute to an anti-inflammatory 23 environment (reviewed in 29). The recent finding that SIVcpz is pathogenic in naturally 24 infected chimpanzees in the wild (28) is consistent with this possibility. 25 on November 13, 2017 by guest http://jvi.asm.org/ Downloaded from infectivity was detected using a galactosidase screen kit from Tropix as recommended by the 11 manufacturer. ß-Galactosidase activities were quantified as relative light units per second 12 using an Orion Microplate Luminometer. TZM-bl cells were also used to determine the 13 coreceptor preference of the SIVagmSab92018ivTF clone. Cells were seeded at 5.000 14 cells/well in 96-well plates overnight and then treated with Maraviroc (10 nM) and/or 15 AMD3100 (10 µM) for 1 hr. Infections were performed using virus stocks containing 16 normalized quantities of p24 or p27 antigen (10 ng). After 48 h of incubation at 37°C, 17 supernatant was removed, and cells were processed for detection of luciferase activity as 18
described above. To further analyze the coreceptor usage of the SIVagmSab92018ivTF clone, 19 GHOST cells were used as previously described (36). The six GHOST cell lines used express 20 CD4 alone or together with the viral coreceptors CCR5, CXCR4, BOB/GPR15 or 21
Bonzo/STRL33 and contain the gene encoding the green fluorescent protein (GFP) under the 22 control of the HIV LTR (36). A total of 5 x 10 4 cells were exposed to virus stocks containing 23 infection the percentage of virally infected GFP-positive cells was analyzed by fluorescence-1 activated cell sorting (FACS). Uninfected cells were used as a negative control. 2 Viral replication in African green monkey PBMCs. PBMCs from SIV uninfected 3 AGMs (n=4), were isolated by density gradient centrifugation over lymphocyte separation 4 media (MP Biomedical, Irvine, CA). Briefly, blood was layered over density gradient media 5 in a ratio of 2:1 and centrifuged at 18 °C at 400×g for 25 min. The monolayer containing 6
PBMCs was resuspended with RPMI1640 media supplemented with 10% heat-inactivated 7 fetal bovine serum (FBS) and 1% penicillin-streptomycin (1 mg/ml, Invitrogen, CA) for 8 subsequent studies. Freshly isolated PBMCs were stimulated with 10 µg PHA per ml of 9 medium for 2 days followed by overnight incubation in IL-2 media. Activated PBMCs 10 (5×10 6 ) were infected with virus stocks containing 4 ng of p27 capsid antigen of the 11 SIVagmSab92018ivTF clone produced by transiently transfected 293T cells or the parental 12 SIVagmSab92018 (EI43) plasma stock at 37 °C for 4 h; cells were then washed extensively 13 to remove any cell-free virus. Cells were maintained in IL-2 media for 4 weeks. Virus 14 production in culture supernatants was monitored weekly by SIV P27 antigen capture assay. 15
An aliquot of PBMCs were also depleted of CD8 + cells employing a positive selection 16 procedure (CD8 microbead kit, Miltenyi Biotech, Auburn, CA). This was done to improve 17 the levels of viral replication since the CD4/CD8 T cell ratio is relatively low (about 1/4) in 18 uninfected AGMs. The CD8 + -depleted cells were then stimulated with 10 µg/ml PHA for 2 19 days, followed by overnight incubation in IL-2 media. 5×10 5 CD8 + -depleted cells were 20 infected as described above for the PBMCs. For 4 weeks, one half of the supernatant was 21 collected every third day and replaced with fresh IL-2-containing media. Virus production in 22 culture supernatants was monitored by SIV p27 antigen capture assay. clone generated in this study will be submitted to GenBank and an accession number will be 4 provided upon acceptance for publication. 5 6 RESULTS 7
Generation of two replication defective SIVagmSab proviral clones by conventional 8

PCR.
Our first attempt to generate infectious molecular clones of Sab92018 involved 9 conventional bulk amplification and cloning of near full-length genome fragments from 10 PBMC DNA. Two such clones, termed E2 and A5, were selected for proviral construction 11 because sequence analysis revealed that both encoded uninterrupted gag, pol, vif, vpr, tat, 12 rev, env and nef genes, as well as intact cis-regulatory sequence elements, such as the TATA 13 box, the primer-binding site, the ribosomal frame shift region at the gag-pol junction, and the 14 poly-purine tract. Both clones were thus reconstructed to contain full-length LTRs. However, 15 biological analysis showed that the two clones produced virions that were only poorly 16 infectious and failed to replicate in CD4+ target cells in vitro (data not shown). Thus, 17 conventional PCR and cloning approaches failed to generate biologically active clones of 18 SIVagmSab92018, despite yielding fragments with a seemingly intact genomic organization. 19 SGA analysis identifies a transmitted/founder SIVagmSab genome. Since plasma 20 was collected from animal EI43 during the acute phase of infection, we reasoned that SGA of 21 plasma viral RNA would allow us to infer the sequence of viruses that had established the 22 infection 9 days earlier (26, 27). We thus used SGA to generate 5' (n=10) and 3' (n=13) 23 genome halves and sequenced them directly ( phylogenetic analysis also revealed one low diversity lineage among both the 5' and 3' 2 amplicons, which comprised sequences that differed by only few nucleotides (indicated by 3 brackets in Fig. 1B ). Such discrete low diversity lineages represent the progeny of T/F 4 viruses, whose sequences can be inferred by determining their consensus sequences (26, 27, 5 33, 62). Since both 5' and 3' consensus sequences were identical in the 298 bp region of 6 sequence overlap, we reasoned that they represented the same T/F virus. Missing LTR 7 sequences were derived by conventional PCR (using a high fidelity polymerase) and direct 8 sequencing, and the entire T/F virus genome was synthesized as two fragments, which were 9 joined at a unique BglI site (Fig. 1C) . 10
The full-length Sab92018 T/F virus was 10,004 bp in length and encoded intact gag, pol, 11 vif, vpr, tat, rev, env and nef genes. Like the previously reported SAB-1 molecular clone and 12 the genomes of SIVsmm and HIV-2 (69), the Sab92018 T/F virus had a single NF-κb binding 13 site in its LTR, three NF-AT interaction sites and duplicated TAR sequences. Known cis-14 regulatory sequence elements were also preserved. Unlike other molecular clones of SIV 15 obtained after extensive in vitro propagation, the Sab92018ivTF env gene encoded a full-16 length gp41 with a cytoplasmic tail of 157 amino acids (aa). The predicted length of the 17 Sab92018ivTF Vpr protein is 138 aa, which is similar to that of SAB-1 (140 aa) but longer 18 than those of SIVagmVer and SIVagmGri (120 aa) (24). As expected, in phylogenetic trees 19 of Env amino acid sequences, Sab92018ivTF clustered closely with SAB-1 and P1, forming a 20 species-specific clade within the SIVagm radiation (Fig. 2) . 21
The SIVagmSab transmitted/founder virus is replication competent. To determine 22 whether the Sab92018ivTF virus produces infectious virus, we infected TZM-bl indicator 23 cells with 293T cell-derived virus stocks containing 10 ng of p27 capsid antigen and 24 determined the ß-galactosidase activities 2 days later. Previously described SAB-1 and TAN-25 on November 13, 2017 by guest http://jvi.asm.org/ Downloaded from 1 clones (24, 69) were used as positive controls. In contrast to the SIVagmSab A5 and E2 1 proviruses derived by conventional PCR, the Sab92018ivTF clone yielded highly infectious 2 viral particles (Fig. 3A) that replicated efficiently in Molt-4 clone 8 cells (Fig. 3B) . To 3 determine whether this was due altered protein expression or particle assembly, we 4 performed western blot analyses. The results showed that A5, E2 and Sab92018ivTF proviral 5 constructs expressed all major viral proteins at levels similar to the SAB-1 positive control 6 (Fig. 3C) . Moreover, transfection derived supernatants contained viral particles that could be 7 pelleted (Fig. 3C) . Thus, the replication block in the A5 and E2 proviruses must be due to 8 defects following protein expression and virion assembly. 9
Next, we analyzed the coreceptor tropism of SIVagm90218ivTF using two specific small 10 molecule coreceptor antagonists, i.e. Maraviroc, which specifically blocks CCR5(R5)-tropic 11 HIV-1 infection, and AMD3100, a specific inhibitor of CXCR4(X4)-mediated HIV-1 entry 12 (reviewed in Ref. 58). The X4-tropic wild-type HIV-1 NL4-3 strain, an R5-tropic derivative 13 thereof containing the gp120 V3 loop of HIV-1 TH014 (55), SIVmac239, and SIVagm SAB-14 1 were analyzed in the same experiment for control. As expected, AMD3100 blocked wild-15 type NL4-3 infection, whereas Maraviroc specifically inhibited the R5-tropic HIV-1 16 derivative (Fig. 3D) . Infection of SIVmac239, SIVagmSAB-1 and SIVagm90218ivTF was 17 inhibited by Maraviroc but not affected by AMD3100 (Fig. 3D) demonstrating that all three 18 molecular clones of SIV utilize R5 but not X4 for entry into TZM-bl cells. (Fig. 3E) . Unexpectedly, Sab92018ivTF utilized BONZO/STRL33 about 2 as efficiently as R5 for entry into GHOST target cells (Fig. 3E) . Sab92018ivTF also infected 3 GHOST cells expressing X4 and BOB/GPR15, albeit with lower efficacy. Thus, like most 4 primary SIV and HIV-1 strains, Sab92018ivTF utilizes R5 for infection but is also able to 5 enter cells via alternative coreceptors, particularly BONZO/STRL33. 6
We next compared the replicative capacities of the Sab92018ivTF clone and its parental 7
SIVagmSab92018 strain in AGM PBMCs. In the presence of CD8 + T cells, Sab92018ivTF 8 replicated efficiently only in the PBMCs from two of four animals. Replication in PBMCs 9 from the remaining two AGMs was markedly reduced, but titers were higher than those of the 10 parental SIVagmSab92018 isolate, which did not replicate to detectable levels (Fig. 4A) . In 11 contrast, both cloned and uncloned SIVagm strains were capable of establishing a productive 12 infection in AGM PBMCs in the absence of CD8 + T cells (Fig. 4B) . Again, the 13 Sab92018ivTF clone consistently replicated with higher efficiency than the parental 14 SIVagmSab92018 isolate in cells derived from all four animals examined. These results 15
demonstrate that the Sab92018ivTF clone shows high replication fitness in primary cells 16 derived from its natural AGM host. 17
To evaluate whether the T/F clone was also able to establish a productive infection in 18 vivo, we initially infected one Caribbean AGM (Chlorocebus sabaeus) intravenously with a 19 virus stock produced by transfection of 293T cells. For comparison, five other animals 20 received the parental SIVagmSab92018 strain. We found that the Sab92018ivTF clone 21 replicated about as efficiently in vivo as the parental SIVagmSab92018 strain (Fig. 5A) . Peak 22 levels of viral RNA were observed at 10 days p. i. for the molecular Sab92018ivTF clone 23 (7.91x10 6 copies/ml) and at 8 days p. i. for the uncloned Sab92018 virus (2.81±1.91x10 5 to 10 6 copies per ml and which was maintained up to day 100 p.i., (Fig.  1   5A) . Thus, the levels of Sab92018ivTF replication during the chronic phase of infection were 2 as high or even higher as those detected in the wild-type SIVagmSab92018-infected animals. 3
To examine further the replication fitness of Sab92018ivTF in vivo three additional AGMs 4 were infected at the German Primate Research Center. The results showed that the SIVagm 5 Sab92018ivTF molecular clone replicated persistently at high levels for almost one year of 6 follow-up (Fig. 5B) . Furthermore, the three infected AGMs maintained stable CD4+ T cell 7 counts ( Fig. 5C ) and did not show signs of disease progression (data not shown). 8
In the present study, we generated and functionally characterized three full-length 11 molecular clones of a strain of SIVagmSab that has only been propagated in its natural host. 12
We found that two clones (A5, E2) derived by conventional PCR produced poorly infectious 13 virions that were replication-defective. In contrast, a proviral clone (Sab92018ivTF) 14 representing a T/F virus was highly infectious and replicated efficiently both in vitro and in 15 vivo. Virus generated from the T/F IMC exhibited biological properties that were very similar 16 to those of the parental SIVagmSab92018 strain, including CCR5 tropism and the ability to 17 establish a productive and persistent infection in AGMs in vivo. Thus, we have generated the 18 first IMC that exhibits the properties of non-pathogenic SIV infection but is not compromised 19 by interim propagation in tissue culture. 20
Conventional PCR can generate in vitro artefacts, especially when used to amplify 21 genetically diverse sequence mixtures such as viral quasispecies (61). Single genome 22 amplification precludes Taq polymerase induced recombination (template switching) and 23 nucleotide misincorporation, thereby ensuring an accurate representation of viral variants as 24 they exist in vivo. Given that animal EI43 was infected with SIVagm from a chronically 25 on November 13, 2017 by guest http://jvi.asm.org/ Downloaded from infected monkey, it was not surprising that the two proviruses derived by conventional PCR 1 were replication defective. Notably, most biologically active SIVagm clones available thus 2 far (3, 155, 9063, TYO, GRI-1, SAB-1, TAN-1) were generated by lambda phage cloning of 3 proviral DNA (1, 4, 13, 24, 25, 69) , which is not prone to these same artefacts. To avoid bulk 4 PCR shortcomings, we opted to clone a T/F provirus inferred from SGA amplicons, a 5 strategy that has yielded replication competent molecular clones in the past (34, 62) . T/F 6 viruses are responsible for initiating productive clinical infections. It is thus not surprising 7 that the T/F IMC of SIVagmSab replicated to high titers both in vitro and in vivo. 8
Sabaeus monkey EI43 was infected by intravenous inoculation with a plasma stock 9 originally derived from a chronically infected sabaeus monkey. Although in this study we 10 focused on cloning only one T/F IMC, it is clear that additional transmitted founder viruses 11 would have been identified had we generate additional SGA amplicons. Recent studies in 12 SIVmac infected rhesus macaques have shown that intravenous infection is more than 2,000-13 fold more efficient than intrarectal infection, and frequently associated with multivariant 14 transmissions (27). Similarly, humans infected with HIV-1 by intravenous routes are more 15 likely to acquire multiple variants than humans exposed by sexual routes (5). Thus, the T/F 16 virus that we identified in the plasma of animal EI43 is likely one of many. Since we cloned a 17 T/F virus that was not subjected to a mucosal bottleneck, we also examined AGMs that were 18 infected intra-rectally with the same plasma stock used to derive SAB92018ivTF. 19 Characterizing the transmitted founder viruses in four such animals, we found one that 20 differed from SAB92018ivT/F by only a single synonymous substitution (Pandrea, Apetrei 21 and Hahn, unpublished observations). These results suggest that SAB92018ivTF will also be 22 capable of infecting AGMs by mucosal transmission routes. 23
In vivo analyses suggest that Sab92018ivTF faithfully reproduced the properties of its 24 parental strain, which has been extensively characterized (10, 14, 15, 17, (49) (50) (51) (52) (53) . All four 25 on November 13, 2017 by guest http://jvi.asm.org/
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Sabaeus monkeys infected with the Sab92018ivTF clone maintained high viral loads without 1 developing immunodeficiency during follow-up. Thus, the newly generated Sab92018ivTF 2 will be useful to characterize viral determinants of non-progression in the natural NHP hosts. 3
For example, it has been suggested that the lack of a vpu gene and the ability of Nef to block 4 T cell activation by down-modulation of TCR-CD3 may contribute to the low levels of 5 immune activation (29). To examine these hypotheses, we have already created derivatives of 6 the Sab92018ivTF clone expressing the SIVgsn Vpu, which antagonizes AGM tetherin (63, 7 74) and the HIV-1 Nef protein that in unable to down-modulate CD3 (64). Preliminary results 8
show that this chimeric SIVagmSab clone is capable of establishing a persistent infection in 9 sabaeus monkeys (Sauermann, Stahl-Hennig and Kirchhoff, unpublished data). Future 10 studies will thus be able to address whether this "HIV-1-like" SIVagmSab derivative causes 11 higher levels of immune activation and is more pathogenic than the original Sab92018ivTF 12
clone. The Sab92018ivTF clone will also be useful to evaluate other determinants of virus 13 transmission and pathogenicity, such as the role of viral properties in the frequency of 14 vertical transmissions (46, 51) In summary, we have generated the first replication-competent molecular clone of 3 SIVagm that has not been adapted to growth in cell culture. Our results suggest that 4
Sab92018ivTF recapitulates the biological properties of the naturally occurring parental 5
SIVagmSab90218 strain and will thus be an important resource to identify those viral 6
properties that contribute to the lack of disease progression in the natural AGM hosts. 
